SFRP5 (Secreted Frizzled Related Protein 5)

A key modulator of WNT signaling with roles in metabolic and inflammatory diseases

Gene Information Card

Symbol SFRP5
Full Name Secreted Frizzled Related Protein 5
Gene Type protein-coding
Chromosomal Location 10q24.1
NCBI Gene ID 6425 ncbi.nlm.nih.gov/gene/6425
Ensembl ID ENSG00000120057
UniProt ID Q5T4F7
OMIM ID 604158
HGNC ID 10778
Aliases FRP-5, SARP3, MGC119277

Description

SFRP5 encodes a member of the secreted frizzled-related protein (SFRP) family, which functions as a soluble modulator of WNT signaling. By binding to WNT ligands, SFRP5 inhibits canonical WNT/β-catenin pathway activation. It is highly expressed in adipose tissue and plays a critical role in adipogenesis, insulin sensitivity, and inflammation. Dysregulation of SFRP5 is implicated in metabolic disorders (obesity, type 2 diabetes), cardiovascular disease, and several cancers (e.g., colorectal, breast, gastric).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Obesity Reduced SFRP5 expression in adipose tissue leads to increased WNT signaling, promoting adipocyte hypertrophy and chronic low-grade inflammation. PMID: 20023638, 21947058
Type 2 Diabetes SFRP5 deficiency impairs insulin sensitivity via WNT-mediated inhibition of PPARγ and GLUT4 expression. PMID: 21947058, 23395176
Colorectal Cancer Epigenetic silencing (promoter hypermethylation) of SFRP5 results in constitutive WNT activation, driving tumorigenesis. PMID: 15173019, 17363565
Breast Cancer Loss of SFRP5 expression correlates with poor prognosis and increased WNT signaling in triple-negative breast cancer. PMID: 23209149
Cardiovascular Disease SFRP5 levels are inversely associated with coronary artery disease; it suppresses WNT-induced vascular inflammation. PMID: 23395176

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.5 Medium
Heart 8.3 Low
Liver 6.1 Low
Pancreas 4.7 Low
Colon 3.2 Low
Breast 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
Adipocytes (differentiated) 15.2 High expression in mature adipocytes
HepG2 2.1 Low expression
MCF7 1.5 Low expression
HT-29 0.8 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Likely loss of start codon; predicted loss of function
c.202C>T (p.Arg68Trp) missense <0.01% Unknown significance; rare in population databases
Promoter hypermethylation epigenetic Variable in tumors Silences SFRP5 expression; common in colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Promoter hypermethylation leading to transcriptional silencing is the primary loss-of-function mechanism in cancer. Rare missense variants (e.g., p.Arg68Trp) may impair WNT-binding ability.

Gain of Function (GOF)

No documented gain-of-function mutations in SFRP5.

Dominant Negative (DN)

No evidence of dominant-negative effects.

Pathways

• WNT signaling pathway (KEGG: hsa04310)
• Adipogenesis (Reactome: R-HSA-381340)
• Regulation of insulin sensitivity (Reactome: R-HSA-163685)

Protein Summary

SFRP5 is a 317-amino-acid secreted glycoprotein containing a cysteine-rich domain (CRD) homologous to the WNT-binding domain of Frizzled receptors. It acts as a decoy receptor, sequestering WNT ligands (e.g., WNT3A, WNT5A) to prevent activation of the canonical WNT/β-catenin pathway. In adipose tissue, SFRP5 promotes adipocyte differentiation and insulin sensitivity while suppressing inflammatory cytokine production. Its expression is epigenetically silenced in many cancers, contributing to uncontrolled WNT signaling and tumor progression.

Related Products

Product name Cat.No. Species Gene ID
SFRP5 Knockout HEK293 Cell Line EDJ-KQ333 Human 6425 Details Get a Quote
SFRP5 Knockout HeLa Cell Line EDJ-KQ54449 Human 6425 Details Get a Quote
SFRP5 Knockout A-549 Cell Line EDJ-KQ62938 Human 6425 Details Get a Quote
SFRP5 Knockout HCT 116 Cell Line EDJ-KQ71409 Human 6425 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: